Literature DB >> 17453171

[Energy ablative therapy of renal tumours].

H C Klingler1.   

Abstract

Solid renal tumours with a diameter <4 cm may be effectively cured by partial nephrectomy but this is associated with a complication rate of 15-20%. In addition, these tumours are more frequently diagnosed in the elderly (<70 years) and 26% are aggressive G3 and potentially hazardous tumours. Since these tumours are frequently unifocal, spherical, peripherally located and easily accessible for minimally invasive approaches, energy ablative techniques are attractive less invasive therapeutic options. These tumours may be treated by freezing (cryoablation) or by heat (radiofrequency ablation, high intensified focused ultrasound). Cryoablation seems to be the most reliable technique with a 1.6% recurrence rate over 3 years follow-up but only 1.8% complications. Conversely skipping renders RFA unreliable in highly vascularised tumours >3 cm with 23% vital tumours to be found at histological work-up. Laparoscopic HIFU is still experimental. Percutaneous techniques are less effective as compared with laparoscopy with recurrence rates ranging between 13-21% (cryoablation) and 14-18% (RFA). In addition, oncological follow-up relies solely on radiological measurements, frequently without histological verification thus making percutaneous techniques unpredictable.

Entities:  

Mesh:

Year:  2007        PMID: 17453171     DOI: 10.1007/s00120-007-1337-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  61 in total

1.  Radio frequency ablation of renal cell carcinoma via image guided needle electrodes.

Authors:  F J McGovern; B J Wood; S N Goldberg; P R Mueller
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

2.  Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience.

Authors:  A R Zlotta; T Wildschutz; G Raviv; M O Peny; D van Gansbeke; J C Noel; C C Schulman
Journal:  J Endourol       Date:  1997-08       Impact factor: 2.942

3.  Intraperitoneal drop metastasis after radiofrequency ablation of pararenal tumor recurrences.

Authors:  Amy E Krambeck; Michael A Farrell; J W Charboneau; Igor Frank; Horst Zincke
Journal:  Urology       Date:  2005-04       Impact factor: 2.649

4.  Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review.

Authors:  D Brooke Johnson; Stephen B Solomon; Li-Ming Su; Edward D Matsumoto; Louis R Kavoussi; Stephen Y Nakada; Timothy D Moon; W Bruce Shingleton; Jeffrey A Cadeddu
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

Review 5.  Renal cell carcinoma: modern surgical approach.

Authors:  Sidney C Abreu; Inderbir S Gill
Journal:  Curr Opin Urol       Date:  2003-11       Impact factor: 2.309

6.  Cryoablation of renal tumours in patients with solitary kidneys.

Authors:  W B Shingleton; P E Sewell
Journal:  BJU Int       Date:  2003-08       Impact factor: 5.588

7.  Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.

Authors:  Ronald J Zagoria; Ashley D Hawkins; Peter E Clark; M Craig Hall; Brian R Matlaga; Raymond B Dyer; Michael Y Chen
Journal:  AJR Am J Roentgenol       Date:  2004-07       Impact factor: 3.959

8.  Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy.

Authors:  Feng Wu; Zhi-Biao Wang; Wen-Zhi Chen; Jin Bai; Hui Zhu; Tian-Yu Qiao
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

9.  The effects of radio frequency ablation on renal function and blood pressure.

Authors:  D Brooke Johnson; Grant D Taylor; Yair Lotan; Arthur I Sagalowsky; Kenneth S Koenemann; Jeffrey A Cadeddu
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

10.  Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients.

Authors:  Inderbir S Gill; Surena F Matin; Mihir M Desai; Jihad H Kaouk; Andrew Steinberg; Ed Mascha; Julie Thornton; Mahmoud H Sherief; Brenda Strzempkowski; Andrew C Novick
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

View more
  1 in total

1.  Ablative therapies for renal tumors.

Authors:  Rajan Ramanathan; Raymond J Leveillee
Journal:  Ther Adv Urol       Date:  2010-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.